AUTHOR=Meesilpavikkai Kornvalee , Dik Willem A. , Schrijver Benjamin , Nagtzaam Nicole M. A. , van Rijswijk Angelique , Driessen Gertjan J. , van der Spek Peter J. , van Hagen P. Martin , Dalm Virgil A. S. H. 

TITLE=A Novel Heterozygous Mutation in the STAT1 SH2 Domain Causes Chronic Mucocutaneous Candidiasis, Atypically Diverse Infections, Autoimmunity, and Impaired Cytokine Regulation

JOURNAL=Frontiers in Immunology

VOLUME=8

YEAR=2017

URL=https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2017.00274

DOI=10.3389/fimmu.2017.00274

ISSN=1664-3224

ABSTRACT=<p>Chronic mucocutaneous candidiasis (CMC) is a primary immunodeficiency characterized by persistent or recurrent skin and mucosal surface infections with <italic>Candida</italic> species. Different gene mutations leading to CMC have been identified. These include various heterozygous gain-of-function (GOF) mutations in signal transducer and activator of transcription 1 (<italic>STAT1</italic>) that are not only associated with infections but also with autoimmune manifestations. Recently, two <italic>STAT1</italic> GOF mutations involving the Src homology 2 (SH2) domain have been reported, while so far, over 50 mutations have been described mainly in the coiled coil and the DNA-binding domains. Here, we present two members of a Dutch family with a novel <italic>STAT1</italic> mutation located in the SH2 domain. T lymphocytes of these patients revealed STAT1 hyperphosphorylation and higher expression of STAT1 target genes. The clinical picture of CMC in our patients could be explained by diminished production of interleukin (IL)-17 and IL-22, cytokines important in the protection against fungal infections.</p>